Short‐term inactivation of CDK12 – an essential gene in mammals – is deleterious for cancer cells and exposes them to vulnerability towards several anticancer agents, particularly those impinging on the DDR [136, 137, 140]. This evidence concerns the gene CDK12 and cancer.